CMOS and CROs have different trajectories: CMOS may be gaining as strategic partners to large bio/pharma companies, but they have a much harder path to navigate
In: Pharmaceutical Technology Europe, Jg. 29 (2017-05-01), Heft 5, S. 12-13
Online
serialPeriodical
Zugriff:
Titel: |
CMOS and CROs have different trajectories: CMOS may be gaining as strategic partners to large bio/pharma companies, but they have a much harder path to navigate
|
---|---|
Autor/in / Beteiligte Person: | Miller, Jim |
Link: | |
Zeitschrift: | Pharmaceutical Technology Europe, Jg. 29 (2017-05-01), Heft 5, S. 12-13 |
Veröffentlichung: | 2017 |
Medientyp: | serialPeriodical |
ISSN: | 1753-7967 (print) |
Sonstiges: |
|